Translating Science into Survival: Report on the Fourth International Cancer Immunotherapy Conference.
Journal
Cancer immunology research
ISSN: 2326-6074
Titre abrégé: Cancer Immunol Res
Pays: United States
ID NLM: 101614637
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
entrez:
4
1
2019
pubmed:
4
1
2019
medline:
5
3
2020
Statut:
ppublish
Résumé
On September 30 to October 3, 2018, in New York City, the Fourth International Cancer Immunotherapy Conference (CICON) was hosted jointly by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology, and the American Association for Cancer Research (AACR). For the fourth straight year, more than 1,400 people attended the 4-day event, which covered the latest advances in cancer immunology and immunotherapy. This year's meeting also coincided with the announcement that the 2018 Nobel Prize in Medicine or Physiology would be awarded to one of CICON's attendees, James P. Allison.
Identifiants
pubmed: 30602506
pii: 7/1/2
doi: 10.1158/2326-6066.CIR-18-0866
doi:
Types de publication
Congress
Langues
eng
Sous-ensembles de citation
IM
Pagination
2-5Informations de copyright
©2019 American Association for Cancer Research.